Skip to main content
. 2017 Jun 8;14(2):1333–1340. doi: 10.3892/ol.2017.6347

Figure 8.

Figure 8.

Effect of ERK1/2 and JNK inhibitors on the invasiveness of MG63/dox cells. A Transwell assay was used to assess the invasion ability of MG63/dox cells treated with As2O3 and ADM, PD098095, or As2O3 and ADM with SP600125. *P<0.05 compared with control group;#P<0.05 compared with the As2O3 and ADM group. ERK1/2, mitogen-activated protein kinase 3/1; JNK, mitogen-activated protein kinase 8; MG63/dox, MG63/doxorubicin-resistant; As2O3, arsenic trioxide; ADM, doxorubicin.